BIOAF (Bioasis Technologies) Cyclically Adjusted FCF per Share: $-0.04 (As of Nov. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOAF Bioasis Technologies Inc BIOAF
12 GF Score
Price $0.00
View Full Analysis

What is Bioasis Technologies Cyclically Adjusted FCF per Share?

Bioasis Technologies BIOAF 12 Cyclically Adjusted FCF per Share is $-0.04 as of Nov. 2022. GuruFocus rates BIOAF with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bioasis Technologies's adjusted free cash flow per share for the three months ended in Nov. 2022 was $-0.004. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.04 for the trailing ten years ended in Nov. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-15), Bioasis Technologies's current stock price is $0.0001. Bioasis Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Nov. 2022 was $-0.04. Bioasis Technologies's Cyclically Adjusted Price-to-FCF of today is .


Bioasis Technologies  (OTCPK:BIOAF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bioasis Technologies Cyclically Adjusted FCF per Share Related Terms


Bioasis Technologies Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bioasis Technologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies Cyclically Adjusted FCF per Share Chart

Bioasis Technologies Annual Data
Trend Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.05 -0.05 -0.04 -0.04

Bioasis Technologies Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.05 -0.04 -0.04

BIOAF vs VRTX, REGN, SGEN: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Bioasis Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioasis Technologies Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Cyclically Adjusted Price-to-FCF falls into.


BIOAF
12GF Score
Bioasis Technologies Inc BIOAF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioasis Technologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bioasis Technologies's adjusted Free Cash Flow per Share data for the three months ended in Nov. 2022 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=-0.004/297.7110*297.7110
=-0.004

Current CPI (Nov. 2022) = 297.7110.

Bioasis Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201302 -0.007 232.166 -0.009
201305 -0.016 232.945 -0.020
201308 -0.018 233.877 -0.023
201311 -0.012 233.069 -0.015
201402 -0.020 234.781 -0.025
201405 -0.009 237.900 -0.011
201408 -0.012 237.852 -0.015
201411 -0.012 236.151 -0.015
201502 -0.008 234.722 -0.010
201505 -0.010 237.805 -0.013
201508 -0.006 238.316 -0.007
201511 -0.006 237.336 -0.008
201602 -0.005 237.111 -0.006
201605 -0.004 240.229 -0.005
201608 -0.008 240.849 -0.010
201611 -0.003 241.353 -0.004
201702 -0.005 243.603 -0.006
201705 -0.010 244.733 -0.012
201708 -0.017 245.519 -0.021
201711 -0.009 246.669 -0.011
201802 -0.020 248.991 -0.024
201805 -0.012 251.588 -0.014
201808 -0.019 252.146 -0.022
201811 -0.001 252.038 -0.001
201902 -0.013 252.776 -0.015
201905 -0.011 256.092 -0.013
201908 -0.012 256.558 -0.014
201911 -0.009 257.208 -0.010
202002 -0.007 258.678 -0.008
202005 -0.004 256.394 -0.005
202008 0.026 259.918 0.030
202011 -0.010 260.229 -0.011
202102 0.008 263.014 0.009
202105 -0.009 269.195 -0.010
202108 -0.013 273.567 -0.014
202111 -0.010 277.948 -0.011
202202 -0.007 283.716 -0.007
202205 -0.006 292.296 -0.006
202208 -0.002 296.171 -0.002
202211 -0.004 297.711 -0.004

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.04 mean?
Bioasis Technologies (BIOAF) has a Cyclically Adjusted FCF per Share of $-0.04 as of Nov. 2022. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bioasis Technologies and its competitors.
Is Bioasis Technologies' Cyclically Adjusted FCF per Share too high?
Bioasis Technologies' current Cyclically Adjusted FCF per Share is $-0.04. Overall, Bioasis Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioasis Technologies' Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Bioasis Technologies' Cyclically Adjusted FCF per Share of $-0.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bioasis Technologies and its competitors. Bioasis Technologies's current Cyclically Adjusted FCF per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioasis Technologies stock overvalued right now?
Bioasis Technologies (BIOAF) has a current Cyclically Adjusted FCF per Share of $-0.04. The current Cyclically Adjusted FCF per Share is $-0.04. Bioasis Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bioasis Technologies (BIOAF), the current Cyclically Adjusted FCF per Share is $-0.04 as of Nov. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioasis Technologies Business Description

Address 157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB).
12GF Score

Get the complete analysis for BIOAF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price